News | October 14, 2022
DKSH acquires two ear care brands
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
DKSH has signed an agreement to acquire two ear care brands from Noru Pharma for Australia, New Zealand, and selected markets in Asia.
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
Campaign to celebrate World Mental Health Day theme "Mental Health in an Unequal World"
The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Subscribe To Our Newsletter & Stay Updated
